Trecator-SC is an anti-tuberculosis medication that contains the compounds thiacetazone and para-aminosalicylic acid. It is prescribed to treat tuberculosis infections when used as part of a multi-drug regimen. The active ingredients work by inhibiting mycolic acid synthesis which is essential for the bacterial cell wall. They also interfere with folate metabolism, leading to accumulation of toxic metabolites in the pathogen. These actions suppress bacterial growth in the lungs and other tissues, reducing the burden of infection. The combined effect of cell wall disruption and metabolic blockade ultimately leads to the death of mycobacterium tuberculosis cells.

Trecator-SC is a medication prescribed to lower elevated blood pressure. It functions as a calcium channel blocker that interferes with the movement of calcium into smooth muscle cells. By reducing calcium entry the drug relaxes the walls of arteries and veins. This relaxation decreases the resistance to blood flow and lowers arterial pressure. The decrease in pressure reduces the workload on the heart and improves oxygen delivery to tissues. The therapeutic effect is achieved through selective inhibition of l-type voltage gated calcium channels in vascular tissue. Overall Trecator-SC provides effective control of hypertension by promoting vessel dilation without affecting heart rhythm.

Trecator sc may cause nausea and vomiting in some patients. Diarrhea and abdominal discomfort are also reported frequently. Headache and dizziness can occur during treatment. A metallic taste in the mouth is noted by many users. Skin reactions such as rash or itching may develop. Loss of appetite and mild weight loss are observed in some cases. Elevated liver enzymes are occasionally detected in blood tests. These side effects are generally mild and often improve with continued use.

Trecator-sc may cause nausea in some patients. It can also lead to vomiting and loss of appetite. Headache and dizziness are reported side effects. A metallic taste in the mouth has been observed. Skin reactions such as rash or itching may occur. Fatigue and weakness are occasionally noted. Changes in liver function tests are sometimes seen.